Session » Rheumatoid Arthritis – Clinical Aspects Poster III: Comorbidities

Date: Tuesday, November 7, 2017

Time: 9:00AM-11:00AM

Meeting: 2017 ACR/ARHP Annual Meeting

9:00AM-11:00AM: Abstract Number: 2360

A Correlation Study between Expanded Cardiovascular Risk Prediction Score for Rheumatoid Arthritis and Nailfold Videocapillaroscopy

9:00AM-11:00AM: Abstract Number: 2398

A Population-Based Cohort Study of Chronic Obstructive Pulmonary Disease Among Patients with Rheumatoid Arthritis: Comorbidity and Mortality

9:00AM-11:00AM: Abstract Number: 2403

Amylin in the Insulin Resistance of Patients with Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 2351

Are Sedentary Behavior and Reduced Physical Activity Associated with Long-Term Cardiovascular Risk in Individuals with Rheumatoid Arthritis?

9:00AM-11:00AM: Abstract Number: 2355

Arterial Wave Reflection and Subclinical Atherosclerosis in Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 2413

Assessment of the Most Distal Sensory Nerves in Patients with Rheumatoid Arthritis with Normal Value of Standard Nerve Conduction Studies

9:00AM-11:00AM: Abstract Number: 2361

Associated Factors of Hypertension and Hyperglycemia Related to Steroid Pulse in Autoimmune Diseases

9:00AM-11:00AM: Abstract Number: 2397

Bilateral Femoral DXA Scan in Patients with Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 2405

Biological Function Integrated Prediction of Severe Radiographic Progression in Rheumatoid Arthritis: A Nested Case Control Study

9:00AM-11:00AM: Abstract Number: 2378

Body Mass Index and Persistence of Conventional Dmards and TNF Inhibitors in Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 2352

Cardiovascular Safety during Treatment with Baricitinib in Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 2358

Chest Pain and Angina Pectoris in Rheumatoid Arthritis: Frequency and Prediction of Cardiovascular Mortality

9:00AM-11:00AM: Abstract Number: 2407

Clinical Significance of Elevated Anti-Cyclic Citrullinated Protein Antibody Titers in Patients with Pulmonary Hypertension

9:00AM-11:00AM: Abstract Number: 2364

Decrease in Cardiovascular Event Excess Risk in Rheumatoid Arthritis Since 2000: A Meta- Analysis of Controlled Studies

9:00AM-11:00AM: Abstract Number: 2394

Differential Effect of Corticosteroids and Biological Dmards on Five-Year Radiographic Progression in Rheumatoid Arthritis: Results from a Weighted Cumulative Exposure Model Developed on the Espoir Cohort

9:00AM-11:00AM: Abstract Number: 2356

Disease Severity Impacts the Relationships of Apelin Concentrations with Arterial Function in Patients with Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 2363

Does Galectin-3 Have Utility As a Biomarker of Subclinical Cardiovascular Disease in RA Patients Independently of RA Disease Activity?

9:00AM-11:00AM: Abstract Number: 2375

Does the Body Mass Index Have Any Influence in the Characteristics of Early Arthritis Patients?

9:00AM-11:00AM: Abstract Number: 2408

Early Frailty Syndrome in Rhematoid Arthitis: Screening Using the Frail Scale

9:00AM-11:00AM: Abstract Number: 2379

Effect of DKK-1 and Osteoprotegerin on Bone Mass in Tightly Controlled Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 2370

Endothelial Nitric Oxide Synthase Gene Polymorphism As a Risk Factor of Hypertension in Patients with Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 2393

Evaluation of Live Zoster Vaccine in a Subset of Patients with Rheumatoid Arthritis Treated with Tofacitinib with or without Methotrexate, and Adalimumab with Methotrexate: Results from a Phase 3b/4 Randomized Trial

9:00AM-11:00AM: Abstract Number: 2383

Frailty and Risk of Fractures in Patients with Rheumatoid Arthritis: Data from the Ontario Best Practices Research Initiative (OBRI)

9:00AM-11:00AM: Abstract Number: 2368

Global Circumferential Strain By Assessed a Feature Tracking Cardiac Magnetic Resonance (CMR) Imaging Was Associated with Myocardial Fibrosis in RA Patients

9:00AM-11:00AM: Abstract Number: 2381

Hematologic Abnormalities during the Use of Low Dose Methotrexate for Rheumatoid Arthritis: A Systematic Review and Meta-Analysis

9:00AM-11:00AM: Abstract Number: 2385

High Incidence of Hepatitis Related to HBV Reactivation in Rheumatoid Arthritis Patients with Resolved Hepatitis B Infection during Rituximab Treatment

9:00AM-11:00AM: Abstract Number: 2366

High Uric Acid As a Risk Factor for Cardiovascular Diseases in Rheumatoid Arthritis Patients

9:00AM-11:00AM: Abstract Number: 2416

Histopathological Change Caused By Biological Treatment in Rheumatoid Arthritis Synovial Tissue

9:00AM-11:00AM: Abstract Number: 2415

Immunogenicity and Persistence of a Prime-Boost Re-Vaccination Strategy for Pneumococcal Vaccines (13-Valent Pneumococcal Conjugate Vaccine + 23-Valent Pneumococcal Polysaccharide Vaccine) in Patients with Rheumatoid Arthritis: A Pilot Study

9:00AM-11:00AM: Abstract Number: 2377

Impact of Body Mass Index and Weight Loss on Incident Disability in Patients with Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 2392

Impact of the Pattern of Interstitial Lung Disease on Mortality in Rheumatoid Arthritis: A Systematic Review and Meta-Analysis

9:00AM-11:00AM: Abstract Number: 2400

In Rheumatoid Arthritis: Vitamin-D Deficiency Is an Outcome and a Cause of Subclinical Renal Impairment

9:00AM-11:00AM: Abstract Number: 2411

In-Hospital Risk of Asthma in Patients with Rheumatoid Arthritis: A Cross-Sectional Nationwide Analysis

9:00AM-11:00AM: Abstract Number: 2384

Incidence and Predictors of Dyspnea on Exertion in a Prospective Cohort of Patients with Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 2391

Incidence of Infections in Early Arthritis

9:00AM-11:00AM: Abstract Number: 2406

Increased Cartilage Damage in Metacarpophalangeal Joints of ACPA Positive Rheumatoid Arthritis (RA) Patients Using T2 Mapping in 3 Tesla Magnetresonance Imaging (MRI)

9:00AM-11:00AM: Abstract Number: 2354

Inflammatory Markers in Relation to Risk Factors for Cardiovascular Disease in the Pre-Symptomatic Phase of Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 2389

Joint Surgery in Rheumatoid Arthritis 1980-2013: A Population-Based Study to Identify Risk Factors and Time Trends in Incidence

9:00AM-11:00AM: Abstract Number: 2414

Knowledge and Adherence to Current Immunization Recommendations in Patients with Rheumatoid Arthritis in Mexico

9:00AM-11:00AM: Abstract Number: 2373

Low or High BMI Negatively Impacts RA Disease Activity in an Asian RA Cohort

9:00AM-11:00AM: Abstract Number: 2412

Mortality and Clinical Features in Rheumatoid Arthritis and Interstitial Lung Disease

9:00AM-11:00AM: Abstract Number: 2362

Novel Biomarkers for the Prediction of Subclinical Coronary Artery Atherosclerosis in Patients with Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 2372

Obesity and the Impact on Treat to Target Goals and Functional Ability in RA. Results from Two Multi-Centre UK Inception Cohorts

9:00AM-11:00AM: Abstract Number: 2374

Obesity Impacts ESR and Not Other Measures of Rheumatoid Arthritis Disease Activity

9:00AM-11:00AM: Abstract Number: 2417

Occult Coronary Plaque Presence and Burden Predict Cardiovascular Events in Patients with Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 2409

Older Age and Male Gender Are Independent Predictors of Quantiferon Positivity Among Adult Rheumatic Patients in a Tertiary Care Center from a BCG Vaccinated Country: Hur-BIO Single Center Real Life Results

9:00AM-11:00AM: Abstract Number: 2365

Poor Cardiovascular Risk Management in Rheumatoid Arthritis Patients Despite an Explicit Cardiovascular Risk Management Program

9:00AM-11:00AM: Abstract Number: 2387

Prevalence of Hepatitis C Virus Infection in Egyptian Patients with Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 2395

Recommendations on the Management of Rheumatoid Arthritis in Patients with Cancer: A Systematic Review of Clinical Practice Guidelines and Consensus Statements

9:00AM-11:00AM: Abstract Number: 2369

Relationship of Bone Mineral Density and Inflammatory Burden with Carotid Plaque Formation in Rheumatoid Arthritis: A 5-Year Prospective Study

9:00AM-11:00AM: Abstract Number: 2382

Reliability of the Biochemical Bone Markers CTX and P1NP during a TNF-Inhibitor Treatment Cycle in Patients with Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 2357

Retinal Vessel Morphological Associations with Systemic Inflammation and Subclinical Atherosclerosis in Patients with Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 2399

Rheumatoid Arthritis Have Lower Glomerular Filtration Rate Compared to Healthy Population: Role of Inflammation

9:00AM-11:00AM: Abstract Number: 2401

Rheumatoid Arthritis with Kidney Dysfunction Contributes to Higher Risk of Cardiovascular Disease Development

9:00AM-11:00AM: Abstract Number: 2402

Rituximab in Rheumatoid Arthritis with Interstitial Lung Disease: A Multicenter Study of 32 Patients

9:00AM-11:00AM: Abstract Number: 2396

Safety and Humoral and Cell-Mediated Immune Responses to Herpes Zoster Vaccine in Patients with Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 2410

Serious Infection Risk in Patients with Rheumatoid Arthritis Compared to Patients with Non-Inflammatory Rheumatic Diseases: A US National Cohort Study

9:00AM-11:00AM: Abstract Number: 2359

Severity of Ischemic and Hemorrhagic Stroke in Patients with Rheumatoid Arthritis Compared with the General Population

9:00AM-11:00AM: Abstract Number: 2367

The Effect of Glucocorticoids on Bone Mineral Density in Patients with Rheumatoid Arthritis: a Systematic Review and Meta-Analysis

9:00AM-11:00AM: Abstract Number: 2371

The Efficacy of Tofacitinib in Patients with Rheumatoid Arthritis Stratified By Baseline Body Mass Index

9:00AM-11:00AM: Abstract Number: 2353

The Relationship between Disease Activity, VEGF and E-Selectin Levels with Arterial Stiffness in Rheumatic Patients Treated with Biological Agents

9:00AM-11:00AM: Abstract Number: 2386

The Risk Factors of Newly Developing/Worsening Pulmonary Abnormalities in Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 2380

The Use of Fibroscan in Detecting Early Liver Fibrosis in RA Patients on Long Term MTX with Normal Liver Enzymes

9:00AM-11:00AM: Abstract Number: 2390

Trends and Predictors of Guideline Adherence for Glucocorticoid-Induced Osteoporosis Prevention in an Early Rheumatoid Arthritis Cohort

9:00AM-11:00AM: Abstract Number: 2404

Use of Dmards after the Diagnosis of Cancers in Patients with RA

9:00AM-11:00AM: Abstract Number: 2376

Weight Histories Expose the Systematic Underestimation of the Risks of Obesity on Mortality in Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 2388

Women and Men with Rheumatoid Arthritis Present with Different Risks for Glucocorticoid-Related Comorbidities

« View all sessions from this meeting

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].